Issue 3/2008
Content (9 Articles)
The US FDA ‘Black Box’ Warning for Topical Calcineurin Inhibitors
Johannes Ring, Matthias Möhrenschlager, Verena Henkel
A Benefit-Risk Review of Systemic Haemostatic Agents
Ian S. Fraser, Robert J. Porte, Peter A. Kouides, Andrea S. Lukes
Frequency and Clinical Relevance of Drug Interactions with Lovastatin and Simvastatin
Tuire Tirkkonen, Anna Ryynänen, Tero Vahlberg, Kerttu Irjala, Timo Klaukka, Risto Huupponen, Kari Laine
Post-Marketing Surveillance of Ischaemic Optic Neuropathy in Male Veterans Co-Prescribed Phosphodiesterase-5 Inhibitors with Organic Nitrates or α-Blockers
Dustin D. French, Curtis E. Margo
Improving the Detection of Subtle IKr-Inhibition
Jean-Philippe Couderc, Scott McNitt, Ollivier Hyrien, Martino Vaglio, Xiajuan Xia, Slava Polonsky, Arthur J. Moss, Wojciech Zareba
Use of Over-the-Counter Analgesics in Patients with Chronic Liver Disease
Simona Rossi, David N. Assis, Monica Awsare, Mark Brunner, Kevin Skole, Jitha Rai, Jocelyn Andrel, Steven K. Herrine, Rajender K. Reddy, Victor J. Navarro
The ‘Power’ of Signal-Detection Algorithms
M. Rezaul Karim, Stephen L. Klincewicz, Chuen L. Yee
The Authors’ Reply
Yasuyuki Matsushita, Yasufumi Kuroda, Shinpei Niwa, Satoshi Sonehara, Chikuma Hamada, Isao Yoshimura